
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pathogenesis of psoriatic arthritis
Carmel B. Stober
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101694-101694
Closed Access | Times Cited: 29
Carmel B. Stober
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101694-101694
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Pharmacological importance of Kunxian Capsule in clinical applications and its adverse effects: A review
Rui-jiao Ma, Kannan Maharajan, Kaiyan Zhuang, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 222-230
Open Access | Times Cited: 31
Rui-jiao Ma, Kannan Maharajan, Kaiyan Zhuang, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 222-230
Open Access | Times Cited: 31
Proteomic biomarkers in psoriatic arthritis
Márcia Regina Rosa Scalcon, Aline Josiane Waclawovsky, Felipe Barreto Schuch, et al.
Clinica Chimica Acta (2025), pp. 120244-120244
Closed Access
Márcia Regina Rosa Scalcon, Aline Josiane Waclawovsky, Felipe Barreto Schuch, et al.
Clinica Chimica Acta (2025), pp. 120244-120244
Closed Access
Recent Advances in Gut Microbiota in Psoriatic Arthritis
Maria Grazia Bonomo, Salvatore D’Angelo, Valentina Picerno, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1323-1323
Open Access
Maria Grazia Bonomo, Salvatore D’Angelo, Valentina Picerno, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1323-1323
Open Access
Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study
Alessia Pacifico, Rosalynn R.Z. Conic, Antonio Cristaudo, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 2934-2934
Open Access | Times Cited: 23
Alessia Pacifico, Rosalynn R.Z. Conic, Antonio Cristaudo, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 2934-2934
Open Access | Times Cited: 23
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
Juan José Alegre Sancho, V. Núñez-Monje, Cristina Campos‐Fernández, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Juan José Alegre Sancho, V. Núñez-Monje, Cristina Campos‐Fernández, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Psoriasis Comorbidities and Their Treatment Impact
Mark Taliercio, Mark Lebwohl
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 405-416
Closed Access | Times Cited: 2
Mark Taliercio, Mark Lebwohl
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 405-416
Closed Access | Times Cited: 2
Interleukin levels and depressive symptoms in psoriatic arthritis patients: insights from a case–control study on socio-demographic factors and disease perception
Marzena Waszczak-Jeka, Paweł Żuchowski, Marta Dura, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1337-1343
Closed Access | Times Cited: 2
Marzena Waszczak-Jeka, Paweł Żuchowski, Marta Dura, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1337-1343
Closed Access | Times Cited: 2
The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis
Xiaoyang Liu, Yan Zhao, Zhanglei Mu, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1703-1713
Open Access | Times Cited: 5
Xiaoyang Liu, Yan Zhao, Zhanglei Mu, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1703-1713
Open Access | Times Cited: 5
Psoriasis, bone and bowel: a comprehensive review and new insights
Fakhreddin Sabooniha
Exploration of Musculoskeletal Diseases (2024) Vol. 2, Iss. 1, pp. 1-19
Open Access | Times Cited: 1
Fakhreddin Sabooniha
Exploration of Musculoskeletal Diseases (2024) Vol. 2, Iss. 1, pp. 1-19
Open Access | Times Cited: 1
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
Philip J. Mease, Richard B. Warren, Peter Nash, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1413-1423
Open Access | Times Cited: 1
Philip J. Mease, Richard B. Warren, Peter Nash, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1413-1423
Open Access | Times Cited: 1
Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
Philip J. Mease, Richard B. Warren, Peter Nash, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1403-1412
Open Access | Times Cited: 1
Philip J. Mease, Richard B. Warren, Peter Nash, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1403-1412
Open Access | Times Cited: 1
Dickkopf-Related Protein 1 (DKK-1) as a Possible Link between Bone Erosions and Increased Carotid Intima-Media Thickness in Psoriatic Arthritis: An Ultrasound Study
Cristina-Elena Biță, Ştefan Cristian Dinescu, Anca‐Lelia Riza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14970-14970
Open Access | Times Cited: 3
Cristina-Elena Biță, Ştefan Cristian Dinescu, Anca‐Lelia Riza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14970-14970
Open Access | Times Cited: 3
Imidazo[1,2-b]pyridazines as IL-17A Inhibitors for Treating Psoriasis, Rheumatoid Arthritis, and Multiple Sclerosis
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 10, pp. 1526-1527
Open Access | Times Cited: 6
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 10, pp. 1526-1527
Open Access | Times Cited: 6
Improvement of Vestibular Neuritis in a Patient with Psoriatic Arthritis following Ixekizumab Administration
Sherry Ershadi, S. Abu Amara, Mark Lebwohl
SKIN The Journal of Cutaneous Medicine (2024) Vol. 8, Iss. 4, pp. 1708-1710
Open Access
Sherry Ershadi, S. Abu Amara, Mark Lebwohl
SKIN The Journal of Cutaneous Medicine (2024) Vol. 8, Iss. 4, pp. 1708-1710
Open Access
Spondyloarthritis and Tietze’s syndrome: A Re-evaluation
Yasunori Matsuki, Tadashi Nakamura
Modern Rheumatology (2024) Vol. 35, Iss. 1, pp. 1-6
Closed Access
Yasunori Matsuki, Tadashi Nakamura
Modern Rheumatology (2024) Vol. 35, Iss. 1, pp. 1-6
Closed Access
Psoriatic Arthritis
Daniela Rossi, Dario Roccatello, Elena Rubini, et al.
Rare diseases of the immune system (2024), pp. 27-55
Closed Access
Daniela Rossi, Dario Roccatello, Elena Rubini, et al.
Rare diseases of the immune system (2024), pp. 27-55
Closed Access
Physiopathological Aspects of Synovial Fluid and Membrane in Psoriatic Arthritis
Amelia Damasco, Roberta Ramonda, Giacomo Cozzi, et al.
Rheumato (2024) Vol. 4, Iss. 4, pp. 193-202
Open Access
Amelia Damasco, Roberta Ramonda, Giacomo Cozzi, et al.
Rheumato (2024) Vol. 4, Iss. 4, pp. 193-202
Open Access
The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions
Xiaoxu Wang, Lingjun Wu, Jing Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117802-117802
Open Access
Xiaoxu Wang, Lingjun Wu, Jing Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117802-117802
Open Access
The Use of Biologic and Targeted Synthetic Disease-Modifying Drugs in the Treatment of Psoriatic Arthritis
Ruqaya Mustafa Ali, Arthur Lau, Lawrence H. Brent
Biologics (2024) Vol. 5, Iss. 1, pp. 1-1
Open Access
Ruqaya Mustafa Ali, Arthur Lau, Lawrence H. Brent
Biologics (2024) Vol. 5, Iss. 1, pp. 1-1
Open Access
The Psoriatic Arthritis Experience in Saudi Arabia from the Rheumatologist and Patient Perspectives
Ibrahim A. Al-Homood, Mohammad I. Fatani, Mohamed Bedaiwi, et al.
Current Rheumatology Reviews (2023) Vol. 19, Iss. 4, pp. 470-478
Open Access | Times Cited: 1
Ibrahim A. Al-Homood, Mohammad I. Fatani, Mohamed Bedaiwi, et al.
Current Rheumatology Reviews (2023) Vol. 19, Iss. 4, pp. 470-478
Open Access | Times Cited: 1
Challenges in Diagnosing Psoriatic Arthritis in Primary Care: A Meta-Ethnographic Study
Ryuichi Ohta, Chiaki Sano
Cureus (2023)
Open Access | Times Cited: 1
Ryuichi Ohta, Chiaki Sano
Cureus (2023)
Open Access | Times Cited: 1
Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?
Derya Yıldırım, Merve Baykul, Yusuf Can Edek, et al.
Biomarkers in Medicine (2023) Vol. 17, Iss. 20, pp. 871-880
Closed Access | Times Cited: 1
Derya Yıldırım, Merve Baykul, Yusuf Can Edek, et al.
Biomarkers in Medicine (2023) Vol. 17, Iss. 20, pp. 871-880
Closed Access | Times Cited: 1
Psoriatic Arthritis: Current status
Vinod Chandran, Ying Ying Leung
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101703-101703
Closed Access | Times Cited: 3
Vinod Chandran, Ying Ying Leung
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101703-101703
Closed Access | Times Cited: 3
Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis
Bogdan Batko
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5926-5926
Open Access | Times Cited: 3
Bogdan Batko
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5926-5926
Open Access | Times Cited: 3
Novel Difluorocyclohexyl Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 2, pp. 160-161
Open Access | Times Cited: 2
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 2, pp. 160-161
Open Access | Times Cited: 2